Clinical, genetic and immunohistochemical characterization of sinonasal tumors with neuroectodermal differentiation
European Archives of Oto-Rhino-Laryngology · 06.02.2026
DOI: 10.1007/s00405-025-09918-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, online erschienen am 06.02.2026. Verfasst von Luis López und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Cáncer, Gobierno del Principado de Asturias.
Abstract (Originalsprache)
PURPOSE: Sinonasal undifferentiated carcinoma (SNUC), sinonasal neuroendocrine carcinoma (SNEC), and olfactory neuroblastoma (ONB) represent a heterogeneous group of high-grade sinonasal tumors with overlapping morphological and immunophenotypic features, making accurate classification challenging. Our aim was to apply genetic and immunohistochemical analyses to reclassify a cohort of cases and to compare their clinical features. METHODS: We analyzed 61 tumors originally diagnosed as ONB (n = 15), SNEC (n = 12), and SNUC (n = 34). Immunohistochemistry was performed for cytokeratin (CK), six neuroendocrine (NE) markers (synaptophysin, chromogranin A, CD56, INSM1, NeuroD1, ASCL1), p16, Ki67, SMARCB1, SMARCA4, and NUT. IDH2 R172 mutation status was assessed by Sanger sequencing and immunohistochemistry. Results were correlated with clinical and follow-up data. RESULTS: Reclassification was required in 22/61 cases (36%) and concerned one SMARCA4-deficient carcinoma, one SMARCB1-deficient carcinomas, one NUT carcinoma, 14 IDH2-mutated carcinomas, and five cases consistent with olfactory carcinoma (OC). A NE-high profile was identified in all reclassified tumour subtypes except SMARCB1-, SMARCA4-, and NUT-rearranged carcinomas, occurring in 8/9 (89%) ONB, 4/5 (80%) OC, 3/9 (33%) SNEC, 6/21 (29%) SNUC, and 5/14 (36%) IDH2-mutated carcinomas. IDH2-mutated carcinomas were found across all 3 diagnostic categories and were associated with significantly better 5-year disease-free survival (83% versus 31%, p = 0.027). ONB patients showed the most favorable outcome with 5-year overall survival of 86% versus 46% for combined SNEC and SNUC (p = 0.133). A tendency toward longer overall survival was also observed for CK-negative tumors (81% versus 42%, p = 0.051) and for NE-high tumors (73% versus 40%, p = 0.086).. No associations were found between Ki67 index and outcome. CONCLUSION: High-grade sinonasal tumors with neuroectodermal differentiation show substantial histological and immunophenotypic overlap, and over one-third required reclassification when applying extended immunohistochemical and genetic profiling. Our findings emphasize the clinical relevance of refining tumor classification, particularly regarding IDH2 mutation status and CK/NE expression patterns, to improve prognostication and therapeutic decision-making.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain.
- Department of Head and Neck Cancer, Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
- Department of Pathology, Hospital Universitario Central de Asturias, Oviedo, Spain.
- Department of Translational Research and of New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
- Department of Head and Neck Cancer, Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain. mhermsen@ispasturias.es.
Förderung
- Instituto de Salud Carlos III
- Centro de Investigación Biomédica en Red de Cáncer
- Gobierno del Principado de Asturias
Zitieren
APA
López, L., García-Marín, R., Cabal, V. N., Lorenzo-Guerra, S. L., Blanco-González, M., Vivanco, B., Sánchez-Fernández, P., Franchi, A., Llorente, J. L., Hermsen, M. A., & López, F. (2026). Clinical, genetic and immunohistochemical characterization of sinonasal tumors with neuroectodermal differentiation. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-025-09918-4
Vancouver
López L, García-Marín R, Cabal VN, Lorenzo-Guerra SL, Blanco-González M, Vivanco B, et al. Clinical, genetic and immunohistochemical characterization of sinonasal tumors with neuroectodermal differentiation. European Archives of Oto-Rhino-Laryngology. 2026. doi:10.1007/s00405-025-09918-4
BibTeX
@article{Lpez2026,
author = {López, Luis and García-Marín, Rocío and Cabal, Virginia N and Lorenzo-Guerra, Sara Lucila and Blanco-González, Marta and Vivanco, Blanca and Sánchez-Fernández, Paula and Franchi, Alessandro and Llorente, José Luis and Hermsen, Mario A and López, Fernando},
title = {Clinical, genetic and immunohistochemical characterization of sinonasal tumors with neuroectodermal differentiation},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2026},
doi = {10.1007/s00405-025-09918-4}
}
EUVIMED